64Cu-DOTATATE PET/MRI for detection of activated macrophages in carotid atherosclerotic plaques: Studies in patients undergoing endarterectomy

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 35, Issue 7, 2015, Pages 1696-1703

  Pedersen, Sune Folke ^a,b   Sandholt, Benjamin Vikjær ^b   Keller, Sune Høgild ^a   Hansen, Adam Espe ^a   Clemmensen, Andreas Ettrup ^a,b   Sillesen, Henrik ^b   Højgaard, Liselotte ^a,b   Ripa, Rasmus Sejersten ^a,b   Kjær, Andreas ^a,b  

^a Nuclear Medicine and PET ^*  (United States)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

atherosclerosis; carotid; endarterectomy; magnetic resonance imaging; positron emission tomography

Indexed keywords

1,4,7,10 TETRAAZACYCLODODECANE N,N',N'',N''' TETRAACETIC ACID DEXTRO PHENYLALANYLTYROSINE OCTREOTATE CU 64; BIOLOGICAL MARKER; CD163 ANTIGEN; CD68 ANTIGEN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT; SOMATOSTATIN RECEPTOR 2; TRACER; UNCLASSIFIED DRUG; 64CU-DOTATATE; CD68 ANTIGEN, HUMAN; CELL SURFACE RECEPTOR; COPPER; DIFFERENTIATION ANTIGEN; LEUKOCYTE ANTIGEN; OCTREOTIDE; ORGANOMETALLIC COMPOUND;

ADULT; AGED; ARTICLE; ATHEROSCLEROTIC PLAQUE; CAROTID ARTERY; CAROTID ARTERY OBSTRUCTION; CAROTID ATHEROSCLEROSIS; CAROTID ENDARTERECTOMY; CEREBROVASCULAR ACCIDENT; CLINICAL ASSESSMENT; CONTROLLED STUDY; CORRELATIONAL STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DRUG UPTAKE; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; IN VIVO STUDY; INJECTION; MACROPHAGE; MACROPHAGE ACTIVATION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PREDICTIVE VALUE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SURGICAL PATIENT; TRANSIENT ISCHEMIC ATTACK; UNIVARIATE ANALYSIS; ANALOGS AND DERIVATIVES; CAROTID STENOSIS; GENETICS; PATHOLOGY; PROCEDURES;

ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; CAROTID STENOSIS; COPPER RADIOISOTOPES; ENDARTERECTOMY, CAROTID; GENE EXPRESSION; HUMANS; MACROPHAGES; MAGNETIC RESONANCE IMAGING; OCTREOTIDE; ORGANOMETALLIC COMPOUNDS; POSITRON-EMISSION TOMOGRAPHY; RECEPTORS, CELL SURFACE;

EID: 84933042374     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.114.305067     Document Type: Article

References (33)

1. Randomised trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European Carotid Surgery Trial (ECST). Lancet 1998 351 1379 87
2. Graebe M, Pedersen SF, Borgwardt L, Højgaard L, Sillesen H, Kjaer A., Molecular pathology in vulnerable carotid plaques: correlation with [18]-fluorodeoxyglucose positron emission tomography (FDG-PET). Eur J Vasc Endovasc Surg 2009 37 714 721. doi: 10.1016/j.ejvs.2008.11.018
3. Pedersen SF, Graebe M, Fisker Hag AM, Højgaard L, Sillesen H, Kjaer A., Gene expression and 18FDG uptake in atherosclerotic carotid plaques. Nucl Med Commun 2010 31 423 429. doi: 10.1097/MNM.0b013e32833767e0
4. Rudd JH, Warburton EA, Fryer TD, Jones HA, Clark JC, Antoun N, Johnström P, Davenport AP, Kirkpatrick PJ, Arch BN, Pickard JD, Weissberg PL., Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography. Circulation 2002 105 2708 2711
5. Armani C, Catalani E, Balbarini A, Bagnoli P, Cervia D., Expression, pharmacology, and functional role of somatostatin receptor subtypes 1 and 2 in human macrophages. J Leukoc Biol 2007 81 845 855. doi: 10.1189/jlb.0606417
6. Rominger A, Saam T, Vogl E, Ubleis C, la Fougère C, Förster S, Haug A, Cumming P, Reiser MF, Nikolaou K, Bartenstein P, Hacker M., In vivo imaging of macrophage activity in the coronary arteries using 68Ga-DOTATATE PET/CT: correlation with coronary calcium burden and risk factors. J Nucl Med 2010 51 193 197. doi: 10.2967/jnumed.109.070672
7. Li X, Samnick S, Lapa C, Israel I, Buck AK, Kreissl MC, Bauer W., 68Ga-DOTATATE PET/CT for the detection of inflammation of large arteries: correlation with18F-FDG, calcium burden and risk factors. EJNMMI Res 2012 2 52. doi: 10.1186/2191-219X-2-52
8. Pfeifer A, Knigge U, Mortensen J, Oturai P, Berthelsen AK, Loft A, Binderup T, Rasmussen P, Elema D, Klausen TL, Holm S, von Benzon E, Højgaard L, Kjaer A., Clinical PET of neuroendocrine tumors using 64Cu-DOTATATE: first-in-humans study. J Nucl Med 2012 53 1207 1215. doi: 10.2967/jnumed.111.101469
9. Ripa RS, Knudsen A, Hag AM, Lebech AM, Loft A, Keller SH, Hansen AE, von Benzon E, Højgaard L, Kjær A., Feasibility of simultaneous PET/MR of the carotid artery: first clinical experience and comparison to PET/CT. Am J Nucl Med Mol Imaging 2013 3 361 371
10. Boyle JJ, Harrington HA, Piper E, Elderfield K, Stark J, Landis RC, Haskard DO., Coronary intraplaque hemorrhage evokes a novel atheroprotective macrophage phenotype. Am J Pathol 2009 174 1097 1108. doi: 10.2353/ajpath.2009.080431
11. Li X, Bauer W, Kreissl MC, Weirather J, Bauer E, Israel I, Richter D, Riehl G, Buck A, Samnick S., Specific somatostatin receptor II expression in arterial plaque: (68)Ga-DOTATATE autoradiographic, immunohistochemical and flow cytometric studies in apoE-deficient mice. Atherosclerosis 2013 230 33 39. doi: 10.1016/j.atherosclerosis.2013.06.018
12. Greaves DR, Gordon S., Macrophage-specific gene expression: current paradigms and future challenges. Int J Hematol 2002 76 6 15
13. Stephen SL, Freestone K, Dunn S, Twigg MW, Homer-Vanniasinkam S, Walker JH, Wheatcroft SB, Ponnambalam S., Scavenger receptors and their potential as therapeutic targets in the treatment of cardiovascular disease. Int J Hypertens 2010 2010 646929. doi: 10.4061/2010/646929
14. Figueroa AL, Subramanian SS, Cury RC, Truong QA, Gardecki JA, Tearney GJ, Hoffmann U, Brady TJ, Tawakol A., Distribution of inflammation within carotid atherosclerotic plaques with high-risk morphological features: a comparison between positron emission tomography activity, plaque morphology, and histopathology. Circ Cardiovasc Imaging 2012 5 69 77. doi: 10.1161/CIRCIMAGING.110.959478
15. Hag AM, Pedersen SF, Christoffersen C, Binderup T, Jensen MM, Jørgensen JT, Skovgaard D, Ripa RS, Kjaer A., (18)F-FDG PET imaging of murine atherosclerosis: association with gene expression of key molecular markers. PLoS One 2012 7 e50908. doi: 10.1371/journal.pone.0050908
16. Tawakol A, Migrino RQ, Bashian GG, Bedri S, Vermylen D, Cury RC, Yates D, LaMuraglia GM, Furie K, Houser S, Gewirtz H, Muller JE, Brady TJ, Fischman AJ., In vivo 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients. J Am Coll Cardiol 2006 48 1818 1824. doi: 10.1016/j.jacc.2006.05.076
17. Finn AV, Nakano M, Polavarapu R, Karmali V, Saeed O, Zhao X, Yazdani S, Otsuka F, Davis T, Habib A, Narula J, Kolodgie FD, Virmani R., Hemoglobin directs macrophage differentiation and prevents foam cell formation in human atherosclerotic plaques. J Am Coll Cardiol 2012 59 166 177. doi: 10.1016/j.jacc.2011.10.852
18. De Paoli F, Staels B, Chinetti-Gbaguidi G., Macrophage phenotypes and their modulation in atherosclerosis. Circ J 2014 78 1775 1781
19. Etzerodt A, Moestrup SK., CD163 and inflammation: biological, diagnostic, and therapeutic aspects. Antioxid Redox Signal 2013 18 2352 2363. doi: 10.1089/ars.2012.4834
20. Ratcliffe NR, Kennedy SM, Morganelli PM., Immunocytochemical detection of Fcgamma receptors in human atherosclerotic lesions. Immunol Lett 2001 77 169 174
21. Aristoteli LP, Møller HJ, Bailey B, Moestrup SK, Kritharides L., The monocytic lineage specific soluble CD163 is a plasma marker of coronary atherosclerosis. Atherosclerosis 2006 184 342 347. doi: 10.1016/j.atherosclerosis.2005.05.004
22. Subramanian S, Tawakol A, Burdo TH, Abbara S, Wei J, Vijayakumar J, Corsini E, Abdelbaky A, Zanni MV, Hoffmann U, Williams KC, Lo J, Grinspoon SK., Arterial inflammation in patients with HIV. JAMA 2012 308 379 386. doi: 10.1001/jama.2012.6698
23. Cho KY, Miyoshi H, Kuroda S, Yasuda H, Kamiyama K, Nakagawara J, Takigami M, Kondo T, Atsumi T., The phenotype of infiltrating macrophages influences arteriosclerotic plaque vulnerability in the carotid artery. J Stroke Cerebrovasc Dis 2013 22 910 918. doi: 10.1016/j.jstrokecerebrovasdis.2012.11.020
24. Montecucco F, Lenglet S, Gayet-Ageron A, Bertolotto M, Pelli G, Palombo D, Pane B, Spinella G, Steffens S, Raffaghello L, Pistoia V, Ottonello L, Pende A, Dallegri F, Mach F., Systemic and intraplaque mediators of inflammation are increased in patients symptomatic for ischemic stroke. Stroke 2010 41 1394 1404. doi: 10.1161/STROKEAHA.110.578369
25. Chen G, Goeddel DV., TNF-R1 signaling: a beautiful pathway. Science 2002 296 1634 1635. doi: 10.1126/science.1071924
26. Parameswaran N, Patial S., Tumor necrosis factor-α signaling in macrophages. Crit Rev Eukaryot Gene Expr 2010 20 87 103
27. Schwanhäusser B, Busse D, Li N, Dittmar G, Schuchhardt J, Wolf J, Chen W, Selbach M., Global quantification of mammalian gene expression control. Nature 2011 473 337 342. doi: 10.1038/nature10098
28. Bucerius J, Mani V, Moncrieff C, Machac J, Fuster V, Farkouh ME, Tawakol A, Rudd JH, Fayad ZA., Optimizing 18F-FDG PET/CT imaging of vessel wall inflammation: the impact of 18F-FDG circulation time, injected dose, uptake parameters, and fasting blood glucose levels. Eur J Nucl Med Mol Imaging 2014 41 369 383. doi: 10.1007/s00259-013-2569-6
29. Graebe M, Borgwardt L, Højgaard L, Sillesen H, Kjaer A., When to image carotid plaque inflammation with FDG PET/CT. Nucl Med Commun 2010 31 773 779. doi: 10.1097/MNM.0b013e32833c365e
30. Jones-Wilson TM, Deal KA, Anderson CJ, McCarthy DW, Kovacs Z, Motekaitis RJ, Sherry AD, Martell AE, Welch MJ., The in vivo behavior of copper-64-labeled azamacrocyclic complexes. Nucl Med Biol 1998 25 523 530
31. Boswell CA, Sun X, Niu W, Weisman GR, Wong EH, Rheingold AL, Anderson CJ., Comparative in vivo stability of copper-64-labeled cross-bridged and conventional tetraazamacrocyclic complexes. J Med Chem 2004 47 1465 1474. doi: 10.1021/jm030383m
32. Shokeen M, Anderson CJ., Molecular imaging of cancer with copper-64 radiopharmaceuticals and positron emission tomography (PET). Acc Chem Res 2009 42 832 841. doi: 10.1021/ar800255q
33. Wadas TJ, Wong EH, Weisman GR, Anderson CJ., Copper chelation chemistry and its role in copper radiopharmaceuticals. Curr Pharm Des 2007 13 3 16